Abstract:Recent studies indicated that oligomeric β -amyloid (A β) peptides are more neurotoxic to cells or tissues than A β monomers and fibrils even though the underlying mechanism of the A β -induced toxicity is still elusive. The discovery of inhibitors that can prevent cytotoxic oligomeric A β formation has become one of vital goals for therapeutic drug development for AD. Meanwhile, it is of fundamental importance to investigate and understand the structure of toxic A β oligomeric assembly, the mechanism of the induced cytotoxicity, the inhibitory mode of action, and the structural-activity relationship of inhibiting amyloid oligomerization. Toward this end, a series of 15 novel cyanine-derived A β peptide aggregation inhibitors have been synthesized aiming at investigating the structural-activity properties of these compounds in the role of AD treatment. Fifteen novel carbazole-based cyanine derivatives bearing various functionalized heteroaromatic electron-accepting moieties including pyridinium, benzothiazolium, quinolinium and acridinium have been synthesized for a systematic structure-activity relationships investigation as useful and potent A β peptide aggregation inhibitors. The binding affinity was characterized by dissociation constants derived from fluorescence titration of cyanine compounds against amyloid full-length A β 1-40, A β 1-42 peptides as well as A β fragments of different regions. The inhibitory effect on A β peptide aggregation was investigated with fluorescence, and transmission electron microscopy, and circular dichroism. The bio-viability was evaluated by cell-based and animal studies. Our studies further affirmed the importance of hydrophobic and Ï€-Ï€ stacking interactions for the association of this class of carbazole-based cyanines with A β peptides and fibrils. Slight structural modification alters the binding affinity to the monomeric and aggregated amyloids and hence the inhibition potency. Fifteen newly designed cyanine derivatives for studying the structural/activity properties of the A β binding and A β aggregation inhibition have been developed. Importantly, such slight structural variation also provides a means to tune the biological properties such as cytotoxicity and protection from A β- induced toxicity for potential clinical applications. Remarkably, seven non-toxic cyanine derived inhibitors for A β peptide self-aggregation are identified which shows therapeutic potential for AD treatment.

Synergistic Inhibitory Effect of Peptide-Organic Coassemblies on Amyloid Aggregation.

Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.

Co-Assembly Induced Transformation of Dipeptide Amyloid-Like Structures into Stimuli-Responsive Supramolecular Materials.

Molecular Integrative Analysis of the Inhibitory Effects of Dipeptides on Amyloid β Peptide 1–42 Polymerization

Hybrid Peptides Attenuate Cytotoxicity of Β-Amyloid by Inhibiting Its Oligomerization: Implication from Solvent Effects

Kinetic Studies of Inhibition of the Amyloid Beta (1–42) Aggregation Using a Ferrocene-Tagged Β-Sheet Breaker Peptide

A Computational Study of Self-Assembled Hexapeptide Inhibitors Against Amyloid-Β (aβ) Aggregation.

Cooperative dissolution of peptidomimetic vesicles and amyloid beta fibrils

Molecular Integrative Study on Inhibitory Effects of Pentapeptides on Polymerization and Cell Toxicity of Amyloid-β Peptide (1–42)

Transformation Of Beta-Sheet Structures Of The Amyloid Peptide Induced By Molecular Modulators

POTENT INHIBITORS FOR OLIGOMERIC B-AMYLOID AGGREGATION

Atomistic Characterization of Binding Modes and Affinity of Peptide Inhibitors to Amyloid-Β Protein

Observation of reduced cytotoxicity of aggregated amyloidogenic peptides with chaperone-like molecules.

Design of a Molecular Hybrid of Dual Peptide Inhibitors Coupled on AuNPs for Enhanced Inhibition of Amyloid Β‐protein Aggregation and Cytotoxicity

Rationally Designed Peptoid Inhibitors of Amyloid‐β Oligomerization

Heteromultivalent peptide recognition by co - assembly of cyclodextrin and calixarene amphiphiles enables inhibition of amyloid fibrillation

A Molecular Integrative Study on the Inhibitory Effects of WRR and ERW on Amyloid Β Peptide (1–42) Polymerization and Cell Toxicity

The Synergistic Effect Between KLVFF and Self-Assembly Chaperones on Both Disaggregation of Beta-Amyloid Fibrils and Reducing Consequent Toxicity.

Α-Helical Motif As Inhibitors of Toxic Amyloid-β Oligomer Generation Via Highly Specific Recognition of Amyloid Surface